Local Control After Robot-assisted Supraglottic Laryngectomy

Evaluation of Local Control 2 Years After Robot-assisted Supraglottic Laryngectomy: a Multicenter Retrospective Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03357107

Enrollment

122

Registered

2017-11-29

Start date

2016-10-01

Completion date

2017-02-28

Last updated

2017-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraglottic Squamous Cell Carcinoma

Brief summary

Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.

Interventions

PROCEDURETransoral robotic surgery (TORS)

All patients underwent primary tumour resection with transoral robotic surgery (TORS) using the daVinci robot (Intuitive Surgical, Sunnyvale CA)

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men or women over 18 years of age * Patients with supra-glottic squamous cell carcinoma from T1 to T3, all stages N * Patients with a robot assisted supra-glottic laryngectomy with at least 2 years follow-up

Exclusion criteria

* Patients for whom follow-up of at least 2 years has not been achieved; * Major patients protected by the law (under guardianship or guardianship); * Patients who expressed opposition to their participation in the study.

Design outcomes

Primary

Measure	Time frame	Description
Local control	2 years after surgery	Proportion of patients without cancer recurrence 2 years after surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026